Carcinogen in Zantac, generics triggers FDA, EU investigates
Bloomberg Global health regulators sounded a coordinated alarm about the possibility that a stomach drug taken by millions of people could be tainted with the same cancer-causing agent that has sparked a worldwide recall of blood-pressure pills. Drug-safety officials in the US and Europe said that they were looking into whether Sanofi heartburn medication Zantac and generic versions made by ...
Read More »